TP53 and neoplasm: Although direct experimental links between p62 and increased immune infiltration remain limited, the observed association of interferon responses, complement, allograft rejection, and p53 signaling with enhanced anti-tumor immunity is well supported by prior studies [1, 15, 53, 69].